Video Abstract – Sargramostim (rhu GM-CSF) and Immune Checkpoint Inhibitors: Combinatorial Therapeutic Studies in Metastatic Melanoma
online resourceposted on 11.01.2022, 15:15 authored by Figshare Future Science GroupFigshare Future Science Group, Ahmad A Tarhini, Ila Joshi, Fiona Garner
The content of this video is based on the authors’ recent review publication in Immunotherapy, ‘Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma’. Read the original article here: Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma | Immunotherapy (futuremedicine.com)
Partner Therapeutics, Inc.
Read the peer-reviewed publication
granulocyte-macrophage colony stimulating factorimmune checkpoint inhibitorsipilimumabmelanomasargramostimpembrolizumabnivolumabimmune-related adverse eventinnate immunityadaptive immunityTumour ImmunologyCancer Therapy (excl. Chemotherapy and Radiation Therapy)Oncology and Carcinogenesis not elsewhere classified